Skip to main content

Table 1 Clinical characteristics of patients with OA

From: Factors associated with physician-reported treatment status of patients with osteoarthritis pain

 

Prescription medication for OAa

Physician treatment for OAb

Non-Rx (n = 218)

Rx (n = 623)

p-value

Self-managed (n = 122)

Physician-treated (n = 719)

p-value

Time since OA diagnosis, n (%)

 

0.2161

 

0.1112

  < 6 months

105 (48.2)

290 (46.5)

 

60 (49.2)

335 (46.6)

 

 6–12 months

3 (1.4)

24 (3.9)

0 (0.0)

27 (3.8)

  > 12 months

5 (2.3)

8 (1.3)

2 (1.6)

11 (1.5)

 Don’t know/missing

105 (48.2)

301 (48.3)

60 (49.2)

346 (48.1)

Number of joints affected by OA, mean (SD)

2.66 (2.02)

3.32 (2.59)

0.0006

2.15 (1.60)

3.32 (2.55)

< 0.0001

Joints affected by OA, n (%)c

 Knee

104 (47.7)

375 (60.2)

0.0014

50 (41.0)

429 (59.7)

0.0001

 Hip

59 (27.1)

209 (33.5)

0.077

23 (18.9)

245 (34.1)

0.0008

 Back

66 (30.3)

246 (39.5)

0.0154

29 (23.8)

283 (39.4)

0.001

 Other

111 (50.9)

292 (46.9)

0.3032

60 (49.2)

343 (47.7)

0.763

Body mass index (kg/m2), mean (SD)

27.64 (5.99)

29.07 (5.71)

0.0018

26.80 (4.87)

29.02 (5.90)

< 0.0001

Physician-rated current OA severity, n (%)d

 

< 0.0001

 

< 0.0001

 Mild

126 (58.1)

195 (31.4)

 

78 (64.5)

243 (33.9)

 

 Moderate

71 (32.7)

330 (53.1)

36 (29.8)

365 (50.9)

 Severe

20 (9.2)

96 (15.5)

7 (5.8)

109 (15.2)

Patient-reported average pain intensity over the last week, n (%)

 

0.0004

 

< 0.0001

 Mild (0–3)

125 (57.3)

257 (41.3)

 

75 (61.5)

307 (42.7)

 

 Moderate (4–6)

58 (26.6)

244 (39.2)

34 (27.9)

268 (37.3)

 Severe (7–10)

35 (16.1)

122 (19.6)

13 (10.7)

144 (20.0)

Health status: EQ-5D-5L index value, mean (SD)e

0.76 (0.26)

0.65 (0.29)

< 0.0001

0.80 (0.23)

0.66 (0.29)

< 0.0001

Functional assessment score, mean (SD)

3.21 (2.73)

4.21 (2.45)

< 0.0001

2.91 (2.83)

4.13 (2.48)

< 0.0001

Charlson Comorbidity Index, mean (SD)f

0.32 (0.66)

0.40 (0.81)

0.1817

0.25 (0.58)

0.40 (0.80)

0.0501

  1. p-value for bivariate comparison (non-Rx vs. Rx; or self-managed vs. physician-treated)
  2. aCurrent prescription medication
  3. bCurrent prescription medication, and/or physician recommendation for physical or occupational therapy, acupuncture, transcutaneous electrical nerve stimulation, or cognitive behavior therapy/psychotherapy
  4. cMay be greater than 100% as multiple joints may be affected. ‘Other’ joints include hand/fingers, neck, shoulder, wrist, ankle, foot/toes, and elbow
  5. dSample size: n = 217 (non-Rx), n = 621 (Rx), n = 121 (self-managed), n = 717 (physician-treated)
  6. eSample size: n = 207 (non-Rx), n = 606 (Rx), n = 118 (self-managed), n = 695 (physician-treated)
  7. fAssessment of comorbid burden [16]
  8. Non-Rx not prescription-medicated, OA osteoarthritis, Rx prescription-medicated, SD standard deviation
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us